CLEVELAND BIOLABS
Cleveland BioLabs is a clinical-stage biotech developing a robust pipeline of drugs for multiple medical and defense applications, with a focus on oncology and tissue protection. The company pursues the research, development, and commercialization of proprietary products that have the potential to treat cancer, prevent, and treat acute radiation syndrome and counteract the toxic effects of radio and chemotherapies for oncology patients. Cleveland BioLabs was established in 2003 and is headquartered in Buffalo, New York.
CLEVELAND BIOLABS
Industry:
Biotechnology Health Care Medical
Founded:
2003-01-01
Address:
Buffalo, New York, United States
Country:
United States
Website Url:
http://www.cbiolabs.com
Total Employee:
51+
Status:
Active
Contact:
7168496820
Total Funding:
111.1 M USD
Technology used in webpage:
SPF Content Delivery Network ZoneEdit
Current Employees Featured
Founder
Stock Details
Investors List
Norma Investment
Norma Investment investment in Post-IPO Equity - Cleveland BioLabs
David Davidovich
David Davidovich investment in Post-IPO Equity - Cleveland BioLabs
Hercules Capital
Hercules Capital investment in Post-IPO Debt - Cleveland BioLabs
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2015-12-24 | Panacela Labs | Cleveland BioLabs investment in Series B - Panacela Labs | 2.9 M USD |
| 2011-10-07 | Panacela Labs | Cleveland BioLabs investment in Series A - Panacela Labs | 37 M USD |
Official Site Inspections
http://www.cbiolabs.com
- Host name: 172.67.218.37
- IP address: 172.67.218.37
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Cleveland BioLabs"
Cleveland BioLabs - Crunchbase Company Profile & Funding
Cleveland BioLabs is a clinical-stage biotech developing a robust pipeline of drugs for multiple medical and defense applications, with a focus on oncology and tissue protection.See details»
Cleveland BioLabs, Inc. - VentureRadar
Nov 15, 2022 Cleveland BioLabs, Inc. (Nasdaq: CBLI) is a clinical-stage biotechnology company with a focus on oncology development. It specializes in research and... ... Find out ...See details»
Cleveland Biolabs, Inc. - AnnualReports.com
Cleveland BioLabs, Inc. is a biotechnology focused on developing biodefense, tissue protection and cancer treatment drugs based on concept of modulation of cell death for therapeutic benefit.See details»
Cleveland Biolabs Company Profile | Management and Employees …
Www.cbiolabs.com . Contact Information. Headquarters. 73 High St, Buffalo, New York, 14203, United States (716) 849-6810. Cleveland Biolabs Profile and History . Cleveland BioLabs, Inc., …See details»
Cleveland Biolabs - LinkedIn
Cleveland BioLabs, Inc. (Nasdaq:CBLI) is a clinical-stage biotechnology company with a focus on oncology and orphan drug development. Since our inception in 2003, we have pursued the …See details»
Cleveland Biolabs Company Profile 2024: Valuation, Investors ...
Cleveland Biolabs General Information Description. Cleveland BioLabs Inc is a biopharmaceutical company. The company is developing novel approaches to activate the immune system and …See details»
Cleveland BioLabs, Inc. and Cytocom Announce Registration …
Jun 17, 2021 FORT COLLINS, Colo. and BUFFALO, N.Y., June 17, 2021 /PRNewswire/ -- Cleveland BioLabs, Inc. (NASDAQ: CBLI), an innovative biopharmaceutical company …See details»
Cleveland BioLabs, Inc. Files Registration Statement on Form S-4 …
Feb 17, 2021 Cleveland BioLabs also makes available free of charge at www.cbiolabs.com (in the "Investors" section), copies of materials that Cleveland BioLabs files with, or furnishes to, …See details»
Cleveland BioLabs, Inc. Files Registration Statement on Form S-4 …
Feb 17, 2021 Combined public entity to develop and commercialize next-generation immune therapies that address unmet needs in oncology, infectious disease, inflammation and auto …See details»
Cleveland BioLabs | Scientist.com
Cbiolabs.com: Headquarters: Buffalo, NY, US Company Type: Small Business (1-10M TTM Revenue) Description Sites Site Badges; Cleveland BioLabs 73 High Street Buffalo, NY, …See details»
Roswell Park Cancer Institute | Cleveland Bio Labs
Jun 15, 2012 Headquarters: Cleveland BioLabs, Inc. 73 High Street Buffalo, NY 14203 Tel: 716-849-6810 Fax: 716-849-6820 View MapSee details»
Cleveland BioLabs Enters Into Agreement to Raise Up to $4 Million ...
Apr 29, 2015 Cleveland BioLabs, Inc. today announced that it has entered into an agreement to sell its equity stake in Incuron, LLC to Dr. Mikhail Mogutov, Chairman of the Board of Directors …See details»
Cleveland BioLabs, Inc. Announces Closing of $14 Million …
Feb 23, 2021 BUFFALO, NY / ACCESSWIRE / February 23, 2021 / Cleveland BioLabs, Inc. (NASDAQ:CBLI), today announced that it has closed its previously announced registered …See details»
Cleveland BioLabs, Inc. and Cytocom Inc. Announce Call to Discuss ...
Jul 6, 2021 During the call, Michael K. Handley, President and Chief Executive Officer of Cytocom, and members of the Cleveland BioLabs Board of Directors will discuss the results of …See details»
Cleveland BioLabs, Inc. Announces $14 Million Registered Direct ...
Feb 19, 2021 BUFFALO, NY / ACCESSWIRE / February 19, 2021 / Cleveland BioLabs, Inc. (NASDAQ:CBLI), today announced that it has entered into definitive agreements with certain …See details»
Cytocom and Cleveland BioLabs Announce Definitive Merger …
Oct 19, 2020 WINTER PARK, FL and BUFFALO, NY/ ACCESSWIRE/ October 19, 2020/ Cytocom, Inc., a leading biopharmaceutical company in the area of immune-modulation, and …See details»
Cleveland BioLabs Announces Launch of Incuron Joint Venture
Apr 26, 2010 BUFFALO, NY--(Marketwire - April 26, 2010) - Cleveland BioLabs, Inc. (NASDAQ: CBLI) today announced the opening of the U.S. office of Incuron, LLC, a joint venture between …See details»
Cleveland BioLabs, Inc. and Cytocom Inc. Announce Call to Discuss ...
Jul 6, 2021 Cleveland BioLabs also makes available free of charge at https://www.cbiolabs.com (in the "Investors" section), copies of materials that Cleveland BioLabs files with, or furnishes …See details»
Cleveland BioLabs Announces Launch Of Incuron Joint Venture To …
Apr 28, 2010 Cleveland BioLabs, Inc. today announced the opening of the U.S. office of Incuron, LLC, a joint venture between CBLI and Bioprocess Capital Ventures, LLC, which triggers the …See details»
Cleveland Biolabs Inc. Announces Launch of Incuron Joint
Apr 26, 2010 BUFFALO, NY--(Marketwire - April 26, 2010) - Cleveland BioLabs, Inc. (NASDAQ: CBLI) today announced the opening of the U.S. office of Incuron, LLC, a joint venture between …See details»